{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:09:36Z","timestamp":1773324576056,"version":"3.50.1"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T00:00:00Z","timestamp":1531094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2016-I2M-3-021"],"award-info":[{"award-number":["2016-I2M-3-021"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,18]]},"DOI":"10.1093\/cid\/ciy566","type":"journal-article","created":{"date-parts":[[2018,7,8]],"date-time":"2018-07-08T07:19:58Z","timestamp":1531034398000},"page":"505-510","source":"Crossref","is-referenced-by-count":10,"title":["A ROADMAP Plan to Address Research Needs for Gonococcal Antimicrobial Resistance in China"],"prefix":"10.1093","volume":"68","author":[{"given":"Xiang-Sheng","family":"Chen","sequence":"first","affiliation":[{"name":"Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, China"},{"name":"National Center for STD Control, Chinese Center for Disease Control and Prevention, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-Ping","family":"Yin","sequence":"additional","affiliation":[{"name":"Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, China"},{"name":"National Center for STD Control, Chinese Center for Disease Control and Prevention, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Yu","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,7,9]]},"reference":[{"key":"key\n\t\t\t\t2019011723583305300_CIT0001","doi-asserted-by":"crossref","first-page":"e0143304","DOI":"10.1371\/journal.pone.0143304","article-title":"Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting","volume":"10","author":"Newman","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0002","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/CMR.00010-14","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future","volume":"27","author":"Unemo","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0003","doi-asserted-by":"crossref","first-page":"e1002344","DOI":"10.1371\/journal.pmed.1002344","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae: global surveillance and a call for international collaborative action","volume":"14","author":"Wi","year":"2017","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0004","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0005","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1258\/ijsa.2011.011267","article-title":"UK national guideline for the management of gonorrhoea in adults, 2011","volume":"22","author":"Bignell","year":"2011","journal-title":"Int J STD AIDS"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0006","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1056\/NEJMc1512757","article-title":"Failure of dual antimicrobial therapy in treatment of gonorrhea","volume":"374","author":"Fifer","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0007","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/jac\/dkx520","article-title":"Prevalence of and factors associated with MDR Neisseria gonorrhoeae in England and Wales between 2004 and 2015: analysis of annual cross-sectional surveillance surveys","volume":"73","author":"Clifton","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0008","doi-asserted-by":"crossref","first-page":"e1002499","DOI":"10.1371\/journal.pmed.1002499","article-title":"Susceptibility of Neisseria gonorrhoeae to azithromycin and ceftriaxone in China: a retrospective study of national surveillance data from 2013 to 2016","volume":"15","author":"Yin","year":"2018","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0009","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S1473-3099(16)30388-7","article-title":"China\u2019s national plan to combat antimicrobial resistance","volume":"16","author":"Xiao","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0010","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/OLQ.0000000000000725","article-title":"An illustration of the potential health and economic benefits of combating antibiotic-resistant gonorrhea","volume":"45","author":"Chesson","year":"2018","journal-title":"Sex Transm Dis"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0011","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1086\/375081","article-title":"The impact of antimicrobial resistance on health and economic outcomes","volume":"36","author":"Cosgrove","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0012","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12879-016-1435-0","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in China: a meta-analysis","volume":"16","author":"Chen","year":"2016","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0013","doi-asserted-by":"crossref","first-page":"e89458","DOI":"10.1371\/journal.pone.0089458","article-title":"Behavioral and socioeconomic risk factors associated with probable resistance to ceftriaxone and resistance to penicillin and tetracycline in Neisseria gonorrhoeae in Shanghai","volume":"9","author":"Trecker","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0014","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/OLQ.0000000000000157","article-title":"Surveillance of antimicrobial susceptibilities of Neisseria gonorrhoeae in Nanning, China, 2000 to 2012","volume":"41","author":"Zhu","year":"2014","journal-title":"Sex Transm Dis"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0015","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1093\/jac\/dku245","article-title":"Antimicrobial resistance, genetic resistance determinants for ceftriaxone and molecular epidemiology of Neisseria gonorrhoeae isolates in Nanjing, China","volume":"69","author":"Chen","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0016","doi-asserted-by":"crossref","DOI":"10.1097\/OLQ.0000000000000859","article-title":"Proceedings of the 2017 International Forum on Gonococcal Infections and Resistance (2017 IFGIR) in Shenzhen, China","author":"Chen","year":"2018","journal-title":"Sex Transm Dis"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0017","doi-asserted-by":"crossref","first-page":"e1001598","DOI":"10.1371\/journal.pmed.1001598","article-title":"Molecular diagnostics for gonorrhoea: implications for antimicrobial resistance and the threat of untreatable gonorrhoea","volume":"11","author":"Low","year":"2014","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0018","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrmicro3217","article-title":"Molecular approaches to enhance surveillance of gonococcal antimicrobial resistance","volume":"12","author":"Goire","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0019","doi-asserted-by":"crossref","first-page":"e0189621","DOI":"10.1371\/journal.pone.0189621","article-title":"Clinical and economic impact of antibiotic resistance in developing countries: a systematic review and meta-analysis","volume":"12","author":"Founou","year":"2017","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0020","volume-title":"What is the economic burden imposed by antimicrobial resistance in Neisseria gonorrhoeae","author":"Tapsall"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0021","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S1473-3099(14)70780-7","article-title":"Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data","volume":"14","author":"Van Boeckel","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0022","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/jac\/dkw013","article-title":"Trends and patterns of antibiotic consumption in Shanghai municipality, China: a 6 year surveillance with sales records, 2009-14","volume":"71","author":"Lin","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0023","doi-asserted-by":"crossref","first-page":"e0190314","DOI":"10.1371\/journal.pone.0190314","article-title":"Trends and patterns of antibiotic consumption in China\u2019s tertiary hospitals: based on a 5 year surveillance with sales records, 2011-2015","volume":"12","author":"Wushouer","year":"2017","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0024","doi-asserted-by":"crossref","first-page":"g4233","DOI":"10.1136\/bmj.g4233","article-title":"China should curb non-prescription use of antibiotics in the community","volume":"348","author":"Fang","year":"2014","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0025","doi-asserted-by":"crossref","DOI":"10.1097\/OLQ.0000000000000819","article-title":"Non-adherence to national guidelines for antibiotic treatment of uncomplicated gonorrhoea in China: results from a nationwide survey","author":"Han","year":"2018","journal-title":"Sex Transm Dis"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0026","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/cid\/ciw648","article-title":"The molecular epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in Australia: a nationwide cross-sectional study, 2012","volume":"63","author":"Trembizki","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0027","doi-asserted-by":"crossref","first-page":"e015447","DOI":"10.1136\/bmjopen-2016-015447","article-title":"Analysis of the potential for point-of-care test to enable individualised treatment of infections caused by antimicrobial-resistant and susceptible strains of Neisseria gonorrhoeae: a modelling study","volume":"7","author":"Turner","year":"2017","journal-title":"BMJ Open"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0028","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/sextrans-2016-053072","article-title":"Rapid accurate point-of-care tests combining diagnostics and antimicrobial resistance prediction for Neisseria gonorrhoeae and Mycoplasma genitalium","volume":"93","author":"Sadiq","year":"2017","journal-title":"Sex Transm Infect"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0029","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.3390\/microorganisms4010014","article-title":"Bacterial multidrug efflux pumps: much more than antibiotic resistance determinants","volume":"4","author":"Blanco","year":"2016","journal-title":"Microorganisms"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0030","doi-asserted-by":"crossref","first-page":"e018587","DOI":"10.1136\/bmjopen-2017-018587","article-title":"Postmarketing studies for novel drugs approved by both the FDA and EMA between 2005 and 2010: a cross-sectional study","volume":"7","author":"Zeitoun","year":"2017","journal-title":"BMJ Open"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0031","first-page":"257","article-title":"Results of a post-marketing surveillance of meropenem administered over 2 g\/day for serious infectious diseases","volume":"68","author":"Wakisaka","year":"2015","journal-title":"Jpn J Antibiot"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0032","first-page":"1","article-title":"Strategy on quality evaluation of post-marketing antibiotics in China","volume":"38","author":"Hu","year":"2013","journal-title":"Chin J Antibiot"},{"key":"key\n\t\t\t\t2019011723583305300_CIT0033","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/bcp.12352","article-title":"Methods and software tools for design evaluation in population pharmacokinetics-pharmacodynamics studies","volume":"79","author":"Nyberg","year":"2015","journal-title":"Br J Clin Pharmacol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/68\/3\/505\/27512703\/ciy566.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,20]],"date-time":"2019-10-20T09:37:09Z","timestamp":1571564229000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/68\/3\/505\/5050687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,9]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,7,9]]},"published-print":{"date-parts":[[2019,1,18]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy566","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2,1]]},"published":{"date-parts":[[2018,7,9]]}}}